Skip to main content
Caplight Logo









Geneus Technologies (Chengdu) Co., Ltd.

Geneus Technologies (Chengdu) Co., Ltd.

Private
ChengduHealthcare & Life Scienceshttp://geneus-tech.com/

Last Round

Series B

Mar 3, 2025

Total Funding Raised

$31.53M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Geneus Technologies (Chengdu) Co., Ltd. is a biotechnology company that develops and commercializes fourth-generation nanopore gene sequencers and related reagents for clinical and research applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

nanopore sequencinggene sequencergenomic sequencinglong-read sequencingnext-gen sequencingNGSbioinformatics softwareclinical diagnosticsprecision medicineMEMSmicroelectromechanical systemssequencing reagentsgenomics tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Geneus Technologies (Chengdu) Co., Ltd. Comparables

Compare Geneus Technologies (Chengdu) Co., Ltd. with similar companies based on industry and business-model similarity.

Geneus Technologies (Chengdu) Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Qitan Tech
89%
Anxuyuan Biotechnology (Shenzhen) Co., Ltd.
87%
Ruhan Gene Tech
79%

Geneus Technologies (Chengdu) Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 3, 2025
Series BMar 2, 2023
Series BSep 29, 2021
Series AJul 31, 2020
AngelJan 29, 2018

Geneus Technologies (Chengdu) Co., Ltd. Investors

Notable investors and investment history

Geneus Technologies (Chengdu) Co., Ltd. investors
InvestorRounds
Wedo Venture PartnersSeries B, Series A
Co-Win VenturesAngel
健壹资本Series B
GF Xinde Investment ManagementSeries B
Shenzhen Dachen Caizhi Venture Capital ManagementSeries B, Series A
Grand Mount CapitalSeries B
华创资本Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 62% MoM, reaching 2.6K.

  • May 16, 2026

    Monthly visitors increased 52% month-over-month.

Geneus Technologies (Chengdu) Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Geneus Technologies (Chengdu) Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Geneus Technologies (Chengdu) Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersChengdu
Employee Range5
Year Founded2017
Last FundingMar 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?